TransMedics Group, Inc. (TMDX) is a Healthcare stock tracked by StreetAlpha. It last closed at $79.79 on Oct 2, down 6.15% on the day. TMDX reports earnings on Wed, Nov 4, 2026. The average 12-month price target from 4 analysts is $126.25 (+58.2% from the last close), with a high of $208.00 and a low of $77.00. Analyst consensus is Strong Buy, based on the latest ratings from 4 firms (3 buy, 1 hold, 0 sell). Over the past 90 days StreetAlpha recorded 1 whale options trade in TMDX, 0% of them bullish and 100% bearish.
Each firm's latest rating on TMDX in the past 90 days
Average 12-month target
$126.25
▲ 58.2% upside
Based on 4 analysts who set a price target on TMDX in the past 90 days. The average target is $126.25, with a high of $208.00 and a low of $77.00, compared with the last close of $79.79.
Highest target$208.00
Average target$126.25
Lowest target$77.00
Latest rating changes
NeedhamTarget raised
Sep 25Buy$106 → $208
TD CowenReiterated
Sep 8Buy$120
UBSMaintained
Aug 5Hold$77
Piper SandlerReiterated
Aug 5Buy$100
NeedhamMaintained
Aug 3Buy$106
Date
Firm
Action
Rating
Price target
Sep 25
Needham
Target raised
Buy
$106 → $208
Sep 8
TD Cowen
Reiterated
Buy
$120
Aug 5
UBS
Maintained
Hold
$77
Aug 5
Piper Sandler
Reiterated
Buy
$100
Aug 3
Needham
Maintained
Buy
$106
Loading…
Whale Options Flow
90D
Total alerts
1
Bullish
0
0%
Bearish
1
100%
Date span
Aug 24 – Aug 24
Loading…
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether TMDX is in one of them and how their past TMDX trades turned out.
